These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7384336)

  • 1. Effect of electroconvulsive therapy (ECT) on plasma tryptophan.
    Whalley LJ; Yates CM; Christie JE
    Psychol Med; 1980 May; 10(2):377-80. PubMed ID: 7384336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addition of L-tryptophan to electroconvulsive treatment in endogenous depression. A double-blind study.
    Kirkegaard C; Møller SE; Bjørum N
    Acta Psychiatr Scand; 1978 Nov; 58(5):457-62. PubMed ID: 362831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electroconvulsive therapy suppresses the neurotoxic branch of the kynurenine pathway in treatment-resistant depressed patients.
    Schwieler L; Samuelsson M; Frye MA; Bhat M; Schuppe-Koistinen I; Jungholm O; Johansson AG; Landén M; Sellgren CM; Erhardt S
    J Neuroinflammation; 2016 Feb; 13(1):51. PubMed ID: 26925576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of electroconvulsive therapy on biopterin and large neutral amino acids in severe, medication-resistant depression.
    Hoekstra R; van den Broek WW; Fekkes D; Bruijn JA; Mulder PG; Pepplinkhuizen L
    Psychiatry Res; 2001 Sep; 103(2-3):115-23. PubMed ID: 11549400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of electroconvulsive therapy on the tryptophan-kynurenine metabolic pathway.
    Guloksuz S; Arts B; Walter S; Drukker M; Rodriguez L; Myint AM; Schwarz MJ; Ponds R; van Os J; Kenis G; Rutten BP
    Brain Behav Immun; 2015 Aug; 48():48-52. PubMed ID: 25765557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in plasma amino acids after electroconvulsive therapy of depressed patients.
    Palmio J; Huuhka M; Saransaari P; Oja SS; Peltola J; Leinonen E; Suhonen J; Keränen T
    Psychiatry Res; 2005 Dec; 137(3):183-90. PubMed ID: 16297983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No early effects of electroconvulsive therapy on tryptophan metabolism and disposition in endogenous depression.
    Mokhtar AS; Morgan CJ; Bradley DM; Badawy AA
    Biol Psychiatry; 1997 Aug; 42(3):201-5. PubMed ID: 9232212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Taurine and glutathione levels in plasma before and after ECT treatment.
    Samuelsson M; Gerdin G; Ollinger K; Vrethem M
    Psychiatry Res; 2012 Jun; 198(1):53-7. PubMed ID: 22453189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the combination of tryptophan and ECT in the treatment of depression. II. Biochemical analysis.
    D'Elia G; Lehmann J; Raotma H
    Acta Psychiatr Scand; 1977 Oct; 56(4):319-34. PubMed ID: 335791
    [No Abstract]   [Full Text] [Related]  

  • 10. Concentration of 5-hydroxyindoleacetic acid, homovanillic acid, and tryptophan in the cerebrospinal fluid of depressed patients before and after ECT.
    Abrams R; Essman WB; Taylor MA; Fink M
    Biol Psychiatry; 1976 Feb; 11(1):85-90. PubMed ID: 1260078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Has tryptophan any anticonvulsive effect?
    Raotma H
    Acta Psychiatr Scand; 1978 Mar; 57(3):253-8. PubMed ID: 645414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood serum concentrations of kynurenic acid in patients diagnosed with recurrent depressive disorder, depression in bipolar disorder, and schizoaffective disorder treated with electroconvulsive therapy.
    Olajossy M; Olajossy B; Wnuk S; Potembska E; Urbańska E
    Psychiatr Pol; 2017 Jun; 51(3):455-468. PubMed ID: 28866716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of electroconvulsive therapy on erythrocyte adenosine triphosphatase activity in depressive illness.
    Whalley LJ; Scott M; Reading HW; Christie JE
    Br J Psychiatry; 1980 Oct; 137():343-5. PubMed ID: 6449973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of relapse with tryptophan depletion following successful treatment with ECT.
    Cassidy F; Murry E; Weiner RD; Carroll BJ
    Am J Psychiatry; 1997 Aug; 154(8):1151-2. PubMed ID: 9247406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement in depressive illness is not associated with altered release of neurophysins over a course of ECT.
    Scott AI; Shering PA; Legros JJ; Whalley LJ
    Psychiatry Res; 1991 Jan; 36(1):65-73. PubMed ID: 2017524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of depressed patients' expectations prior to electroconvulsive therapy on its effectiveness and tolerability (Exp-ECT): a prospective study.
    Krech L; Belz M; Besse M; Methfessel I; Wedekind D; Zilles D
    Eur Arch Psychiatry Clin Neurosci; 2018 Dec; 268(8):809-817. PubMed ID: 28940099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor plasma levels in depression and following electroconvulsive therapy.
    Ryan KM; McLoughlin DM
    Eur Arch Psychiatry Clin Neurosci; 2018 Dec; 268(8):839-848. PubMed ID: 29968119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electroconvulsive Therapy in the Elderly: New Findings in Geriatric Depression.
    Geduldig ET; Kellner CH
    Curr Psychiatry Rep; 2016 Apr; 18(4):40. PubMed ID: 26909702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S100 and impact of ECT on depression and cognition.
    Arts B; Peters M; Ponds R; Honig A; Menheere P; van Os J
    J ECT; 2006 Sep; 22(3):206-12. PubMed ID: 16957538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of electroconvulsive therapy on peripheral adrenoceptors, plasma, noradrenaline, MHPG and cortisol in depressed patients.
    Werstiuk ES; Coote M; Griffith L; Shannon H; Steiner M
    Br J Psychiatry; 1996 Dec; 169(6):758-65. PubMed ID: 8968635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.